Changes in Insulin: Glucose, Glucagon: Glucose, and Insulin: Glucagon Ratios Correlate with Glycemic Response in Patients with Type 2 Diabetes Treated with Saxagliptin Plus Dapagliflozin Add-on to Metformin Therapy

被引：0
|
作者：
Hansen, Lars
Iqbal, Nayyar
Elkholm, Ella
Chen, Hungta
Cook, William
Hirshberg, Boaz
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1212-P
引用
收藏
页码：A313 / A313
页数：1
相关论文
共 50 条
  • [41] IMPROVED GLYCEMIC CONTROL WITH INSULIN GLARGINE VERSUS PIOGLITAZONE AS ADD-ON THERAPY TO SULFONYLUREA OR METFORMIN IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES MELLITUS
    Meneghini, Luigi F.
    Traylor, Louise
    Schwartz, Sherwyn L.
    ENDOCRINE PRACTICE, 2010, 16 (04) : 588 - 599
  • [42] Sustained 52 week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin vs dual therapy with sitagliptin as add-on to metformin in uncontrolled type 2 diabetes
    Handelsman, Y.
    Mathieu, C.
    Del Prato, S.
    Johnsson, E.
    Kurlyandskaya, R.
    Iqbal, N.
    Garcia-Sanchez, R.
    Rosenstock, J.
    DIABETOLOGIA, 2017, 60 : S406 - S406
  • [43] Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial
    Araki, Eiichi
    Onishi, Yukiko
    Asano, Michiko
    Kim, Hyosung
    Yajima, Toshitaka
    DIABETES OBESITY & METABOLISM, 2017, 19 (04): : 562 - 570
  • [44] Add-on therapy with Kos inhaled insulin is as efficacious as add-on therapy with Lantus in poorly controlled type 2 diabetic patients treated with sulfonylureas or metformin
    Hausmann, M
    Dellweg, S
    Heinemann, L
    Buchwald, A
    Heise, T
    DIABETOLOGIA, 2005, 48 : A297 - A297
  • [45] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Pfuetzner, A.
    Gurieva, I
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 168S - 169S
  • [46] Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
    Cowart, Kevin
    Carris, Nicholas W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1329 - 1330
  • [47] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Gurieva, I.
    Pfuetzner, A.
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 226 - 227
  • [48] DAPAGLIFLOZIN PLUS SAXAGLIPTIN ADD-ON TO METFORMIN MAINTAINS REDUCED LIVER FAT AND ADIPOSE TISSUE VOLUMES IN PATIENTS WITH TYPE 2 DIABETES OVER 122 WEEKS
    Johansson, Lars
    Hockings, Paul
    Frias, Juan P.
    Suchower, Lisa
    Maaske, Jill
    Iqbal, Nayyar
    Wilding, John P. H.
    HEPATOLOGY, 2020, 72 : 1048 - 1048
  • [49] Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin
    Shinohara, Yasutake
    Jojima, Teruo
    Kamiga, Yusuke
    Sakurai, Shintaro
    Iijima, Toshie
    Tomaru, Takuya
    Akutsu, Ikuo
    Inoue, Teruo
    Usui, Isao
    Aso, Yoshimasa
    MEDICAL PRINCIPLES AND PRACTICE, 2024, 33 (06) : 569 - 577
  • [50] Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
    Berlie, Helen
    Hurren, Kathryn M.
    Pinelli, Nicole R.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 165 - 174
12345